Skip to main content
Premium Trial:

Request an Annual Quote

Axela, Cronus Ink Distribution Deal for UK, Ireland

NEW YORK (GenomeWeb News) – Cronus Technologies and Axela today announced a distribution deal to market Axela's instruments in the UK and Ireland.

Cronus will manage the sales and support of Axela's flow-through systems in both countries under the terms of the deal. The systems include the fully automated Ziplex Research System for gene and protein microarray analysis, and the dotLab mX System for real-time, multiplex immunoassays. Cronus will also market Axela's panelPlus Technology for creating custom multiplex panels for flow-through biomarker analysis.

"The Ziplex and dotLab mX product range adds another string to our biomarker discovery and validation portfolio and allows us to truly collaborate with our customers in a meaningful and strategic way," Kevin Fairman, CEO of Cronus, said in a statement. "This positive addition combined with a great working relationship with the Axela team will allow our customers to push the boundaries and time constraints in biomarker research."

The companies did not reveal the terms of the deal, which follows an agreement Toronto-based Axela inked with Digilab in August to distribute Axela's products in the US.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.